Andreas Unterberg

ORCID: 0000-0003-3742-3288
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Glioma Diagnosis and Treatment
  • Neurosurgical Procedures and Complications
  • Meningioma and schwannoma management
  • Traumatic Brain Injury Research
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Intracranial Aneurysms: Treatment and Complications
  • Cerebrospinal fluid and hydrocephalus
  • Brain Metastases and Treatment
  • Acute Ischemic Stroke Management
  • Spinal Fractures and Fixation Techniques
  • Cardiac Arrest and Resuscitation
  • Immune cells in cancer
  • Spine and Intervertebral Disc Pathology
  • Cancer Genomics and Diagnostics
  • Trauma and Emergency Care Studies
  • Neurofibromatosis and Schwannoma Cases
  • Radiomics and Machine Learning in Medical Imaging
  • Vascular Malformations Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • S100 Proteins and Annexins
  • Head and Neck Surgical Oncology
  • Advanced MRI Techniques and Applications
  • Spinal Dysraphism and Malformations
  • Anesthesia and Neurotoxicity Research

Heidelberg University
2016-2025

University Hospital Heidelberg
2016-2025

University of Milano-Bicocca
2024

Neurological Surgery
2024

German Cancer Research Center
2009-2022

Addenbrooke's Hospital
2022

University of Groningen
2022

Deutschen Konsortium für Translationale Krebsforschung
2022

Antwerp University Hospital
2022

University of Antwerp
2022

10.1016/j.ccr.2012.08.024 article EN publisher-specific-oa Cancer Cell 2012-10-01

<b><i>Background:</i></b> Intracranial aneurysm with and without subarachnoid haemorrhage (SAH) is a relevant health problem: The overall incidence about 9 per 100,000 wide range, in some countries up to 20 100,000. Mortality rate conservative treatment within the first months 50–60%. About one third of patients left an untreated will die from recurrent bleeding 6 after recovering bleeding. prognosis further influenced by vasospasm, hydrocephalus, delayed ischaemic...

10.1159/000346087 article EN Cerebrovascular Diseases 2013-01-01

Medulloblastoma is the most common brain tumour in children; using whole-genome sequencing of samples authors show that clinically challenging Group 3 and 4 tumours can be tetraploid, reveal expression first medulloblastoma fusion genes identified. malignant children. Four papers published 2 August 2012 issue Nature use other techniques to produce a detailed picture genetics genomics this condition. Notable findings include identification recurrent mutations not previously implicated...

10.1038/nature11284 article EN cc-by-nc-sa Nature 2012-07-24

Background and Purpose— Decompressive surgery (hemicraniectomy) for life-threatening massive cerebral infarction represents a controversial issue in neurocritical care medicine. We report here the 30-day mortality 6- 12-month functional outcomes from DESTINY trial. Methods— (ISRCTN01258591) is prospective, multicenter, randomized, controlled, clinical trial based on sequential design that used after 30 days as first end point. When this point was reached, patient enrollment interrupted per...

10.1161/strokeaha.107.485649 article EN Stroke 2007-08-10

Intracerebral hemorrhage (ICH) accounted for 9% to 27% of all strokes worldwide in the last decade, with high early case fatality and poor functional outcome. In view recent randomized controlled trials (RCTs) management ICH, European Stroke Organisation (ESO) has updated its evidence-based guidelines ICH.A multidisciplinary writing committee 24 researchers from 11 countries identified 20 questions relating ICH created recommendations based on evidence RCTs using Grading Recommendations...

10.1111/ijs.12309 article EN International Journal of Stroke 2014-08-24
Daniel F. Hanley Richard E. Thompson Michael Rosenblum Gayane Yenokyan Karen Lane and 95 more Nichol McBee Steven Mayo Amanda J. Bistran-Hall Dheeraj Gandhi W. Andrew Mould Natalie Ullman Hasan Ali J. Ricardo Carhuapoma Carlos S. Kase Kennedy R. Lees Jesse Dawson Alastair Wilson Joshua Betz Elizabeth A. Sugar Yi Hao Radhika Avadhani Jean-Louis Caron Mark R. Harrigan Andrew P. Carlson Diederik Bulters Didier Ledoux Judy Huang Cully A. Cobb Gaurav Gupta Ryan S. Kitagawa Michael R. Chicoine Hiren C. Patel Robert Dodd Paul J. Camarata Stacey Q Wolfe Agnieszka Stadnik Patricia Lynn Money Patrick Mitchell Rosario Sarabia Sagi Harnof Pál Barzó Andreas Unterberg Jeanne Teitelbaum Weimin Wang Craig S. Anderson A. D. Mendelow Barbara Gregson Scott Janis Paul Vespa Wendy Ziai Mario Zuccarello Issam A. Awad Azmil H. Abdul‐Rahim Amal Abou‐Hamden Michael Abraham Azam Ahmed Carlos Alarcon Alba E. François Aldrich David Altschul Sepideh Amin‐Hanjani Doug Anderson Safdar Ansari David Antezana Agnieszka Ardelt Fuat Arikán M. Báguena Alexandra Baker Steven J. Barrer Kyra J. Becker Thomas Bergman Azize Boström Jamie Braun Peter G. Brindley William C. Broaddus Robert H. Brown András Büki Bing Cao Ying Cao Julián Carrión‐Penagos Julio A. Chalela Tiffany Chang Indalecio Moran Chorro Shakeel A. Chowdhry Luisa Corral László Csiba Jason M. Davies Alberto Torres Díaz Colin P. Derdeyn Michael N. Diringer Rachel Dlugash Robert D. Ecker Tracey Economas Pedro Enríquez Erzsébet Ezer Yuhua Fan Hua Feng Douglas Franz William D. Freeman Matthew R. Fusco Walter Galicich

10.1016/s0140-6736(19)30195-3 article EN The Lancet 2019-02-10

The CD133 antigen has been identified as a putative stem cell marker in normal and malignant brain tissues. In gliomas, it is used to enrich subpopulation of highly tumorigenic cancer cells. According the hypothesis, CD133-positive cells determine long-term tumor growth and, therefore, are suspected influence clinical outcome. To date, correlation between expression primary tissues patients' prognosis not reported.To address this question, we analyzed series 95 gliomas various grade...

10.1158/1078-0432.ccr-07-0932 article EN Clinical Cancer Research 2008-01-01

Early decompressive hemicraniectomy reduces mortality without increasing the risk of very severe disability among patients 60 years age or younger with complete subtotal space-occupying middle-cerebral-artery infarction. Its benefit in older is uncertain.

10.1056/nejmoa1311367 article EN New England Journal of Medicine 2014-03-20

Recently, we described a machine learning approach for classification of central nervous system tumors based on the analysis genome-wide DNA methylation patterns [6]. Here, report methylation-based (CNS) tumor diagnostics conducted in our institution between years 2015 and 2018. In this period, more than 1000 from neurosurgical departments Heidelberg Mannheim referred external institutions were subjected to diagnostic purposes. We describe current integrated diagnosis CNS with focus...

10.1007/s00401-018-1879-y article EN cc-by Acta Neuropathologica 2018-07-02

This article represents the recommendations for management of spontaneous intracerebral haemorrhage European Stroke Initiative (EUSI). These are endorsed by 3 societies which represented in EUSI: Council, Neurological Society and Federation Societies.

10.1159/000094831 article EN Cerebrovascular Diseases 2006-01-01
Christian Koelsche Daniel Schrimpf Damian Stichel Martin Sill Felix Sahm and 95 more David Reuß Mirjam Blattner Barbara C. Worst Christoph E. Heilig Katja Beck Peter Horak Simon Kreutzfeldt Elke Paff Sebastian Stark Pascal D. Johann Florian Selt Jonas Ecker Dominik Sturm Kristian W. Pajtler Annekathrin Reinhardt Annika K. Wefers Philipp Sievers Azadeh Ebrahimi Abigail K. Suwala Francisco Fernández‐Klett Belén Casalini Andrey Korshunov Volker Hovestadt F. Kommoss Mark Kriegsmann Matthias Schick Melanie Bewerunge‐Hudler Till Milde Olaf Witt Andreas E. Kulozik Marcel Kool Laura Romero‐Pérez Thomas G. P. Grünewald Thomas Kirchner Wolfgang Wick Michael Platten Andreas Unterberg Matthias Uhl Amir Abdollahi Jürgen Debus Burkhard Lehner Christian Thomas Martin Hasselblatt Werner Paulus Christian Hartmann Ori Staszewski Marco Prinz Jürgen Hench Stephan Frank Yvonne M.H. Versleijen‐Jonkers Marije E. Weidema Thomas Mentzel Klaus Griewank Enrique de Álava Juan Díaz‐Martín Miguel Á. Idoate Kenneth Tou En Chang Sharon Y. Y. Low Adrián Cuevas-Bourdier Michel Mittelbronn Martin Mynarek Stefan Rutkowski Ulrich Schüller Viktor Mautner Jens Schittenhelm Jonathan Serrano Matija Snuderl Reinhard Büttner Thomas Klingebiel Rolf Buslei Manfred Gessler Pieter Wesseling Winand N.M. Dinjens Sebastian Brandner Zane Jaunmuktane Iben Lyskjær Peter Schirmacher Albrecht Stenzinger Benedikt Brors Hanno Glimm Christoph Heining Òscar M. Tirado Miguel Sáinz‐Jaspeado Jaume Mora Javier Alonso Xavier García del Muro Sebastián Moran Manel Esteller Jamal Benhamida Marc Ladanyi Eva Wardelmann Cristina R. Antonescu Adrienne M. Flanagan Uta Dirksen Peter Hohenberger

Abstract Sarcomas are malignant soft tissue and bone tumours affecting adults, adolescents children. They represent a morphologically heterogeneous class of some entities lack defining histopathological features. Therefore, the diagnosis sarcomas is burdened with high inter-observer variability misclassification rate. Here, we demonstrate classification using machine learning classifier algorithm based on array-generated DNA methylation data. This sarcoma trained dataset 1077 profiles from...

10.1038/s41467-020-20603-4 article EN cc-by Nature Communications 2021-01-21

In glioma-in contrast to various other cancers-the impact of T-lymphocytes on clinical outcome is not clear. We investigated the relevance and regulation T-cell infiltration in glioma.T-cell subpopulations from entire sections 93 WHO°II-IV gliomas were computationally identified using markers CD3, CD8, Foxp3; survival analysis was then done primary glioblastomas (pGBM). Endothelial cells expressing cellular adhesion molecules (CAM) similarly quantified same glioma tissues. Influence...

10.1158/1078-0432.ccr-10-2557 article EN Clinical Cancer Research 2011-04-09

Stem-like tumor cells comprise a highly tumorigenic and therapy-resistant subpopulation, which is believed to substantially influence initiation therapy resistance in glioma. Currently, therapeutic, drug-induced differentiation considered as promising approach eradicate this tumor-driving cell population; retinoic acid well known potent modulator of proliferation normal stem cells. In glioma, knowledge about the efficacy acid-induced target stem-like pool could have therapeutic...

10.1158/1078-0432.ccr-09-1800 article EN Clinical Cancer Research 2010-05-05
Coming Soon ...